Design Therapeutics (DSGN) Amortizatization of Intangibles (2020 - 2026)

Design Therapeutics (DSGN) reported Amortizatization of Intangibles of $147000.0 for Q1 2026, down 86.13% on a YoY basis from $1.1 million in Q1 2025, and down 71.29% sequentially from $512000.0 in Q4 2025.

Design Therapeutics (DSGN) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Design Therapeutics (DSGN) has 7 years of Amortizatization of Intangibles data on file, last reported at $147000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Amortizatization of Intangibles fell 86.13% year-over-year to $147000.0; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (down 57.66% YoY), and the FY2025 full-year result was $3.3 million, down 47.52% from the prior year.
  • Amortizatization of Intangibles retreated to $147000.0 in Q1 2026, from $512000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.8 million in Q4 2023 to a low of -$19000.0 in Q1 2022.
  • A 5-year average of $1.0 million and a median of $1.1 million in 2025 frame the typical range for Amortizatization of Intangibles.
  • Across the five-year window, Amortizatization of Intangibles plunged 112.67% in 2022 and soared 6110.53% in 2023, its largest moves.
  • Tracing DSGN's Amortizatization of Intangibles over 5 years: stood at $899000.0 in 2022, then soared by 104.23% to $1.8 million in 2023, then dropped by 21.68% to $1.4 million in 2024, then sank by 64.39% to $512000.0 in 2025, then sank by 71.29% to $147000.0 in 2026.
  • Business Quant data shows DSGN's Amortizatization of Intangibles at $147000.0 in Q1 2026, $512000.0 in Q4 2025, and $767000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Design Therapeutics 735.98 Mn 513.16 Mn - 147,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 147,000.00
Mar 31, 2026 147,000.00
Dec 31, 2025 512,000.00
Dec 31, 2025 512,000.00
Sep 30, 2025 767,000.00
Sep 30, 2025 767,000.00
Jun 30, 2025 914,000.00
Jun 30, 2025 914,000.00
Mar 31, 2025 1.06 Mn
Mar 31, 2025 1.06 Mn
Dec 31, 2024 1.44 Mn
Dec 31, 2024 1.44 Mn
Sep 30, 2024 1.46 Mn
Sep 30, 2024 1.46 Mn
Jun 30, 2024 1.57 Mn
Jun 30, 2024 1.57 Mn
Mar 31, 2024 1.73 Mn
Mar 31, 2024 1.73 Mn
Dec 31, 2023 1.84 Mn
Dec 31, 2023 1.84 Mn